The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Mirena (levonorgestrel-releasing intrauterine system), extending the duration of use for up to 8 ...

The Mirena intrauterine device (IUD) is a long-acting contraceptive that works by releasing synthetic hormones into the uterus. Side effects of Mirena IUDs include changes in vaginal bleeding. Many ...

A Dec. 19 Health section article incorrectly described Depo-Provera as containing "higher levels of the same hormone" as the new intrauterine device Mirena. Depo-Provera is a progestin-only ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer, a leader in women's healthcare, announced today that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) that ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer, a leader in women's healthcare, today announced the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) that extends the ...

(RTTNews) - German pharmaceutical company Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) announced Friday that Mirena (52mg LNG IUS), its long-acting reversible intrauterine system, received regulatory approval ...

The Food and Drug Administration (FDA) has expanded the approval of Mirena (levonorgestrel-releasing intrauterine system) for up to 7 years of pregnancy prevention. Previously, the intrauterine device ...